4//SEC Filing
Cappello Joseph 4
Accession 0001415889-24-030004
CIK 0001231457other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 8:45 PM ET
Size
7.4 KB
Accession
0001415889-24-030004
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Cappello Joseph
VP, Pharmaceutical Development
Transactions
- Award
Stock Option (right to buy)
2024-12-18+39,000→ 39,000 totalExercise: $2.29Exp: 2034-12-17→ Common Stock (39,000 underlying) - Award
Common Stock
2024-12-18+29,000→ 43,653 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. 25% of the RSUs vest on August 1, 2025, and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.
- [F2]25% of the shares vest on August 1, 2025, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Documents
Issuer
GENELUX Corp
CIK 0001231457
Entity typeother
Related Parties
1- filerCIK 0001939198
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 8:45 PM ET
- Size
- 7.4 KB